Trade VIVS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
VivoSim Labs, Inc. (VIVS) is trading at US$0.16, down 7.63% today as of Oct 14, 16:00 EDT. The company has a market capitalisation of US$3.83M. Over the past 52 weeks, VIVS has traded between US$0.16 and US$3.40. On Syfe you can trade VIVS with $0 commission and add it to your watchlist.
| Previous close | US$0.17 |
|---|---|
| Market cap | US$3.83M |
| 52-week range | US$0.16 – US$3.40 |
| Volume | 348.09K |
| Exchange | US |
VivoSim Labs, Inc.
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Year: 2011
VivoSim Enters China Market With Initial Preclinical Testing Contracts
Jul 21, 1:35 PM · MT Newswires
VivoSim Labs Prices $4 Million Private Placement of Stock, Warrants; Shares Fall Pre-Bell
Jul 16, 1:19 PM · MT Newswires
VivoSim Receives $5 Million Eli Lilly Milestone Payment, Issues Fiscal 2027 Revenue Growth Outlook
Jul 15, 1:12 PM · MT Newswires
VivoSim Labs, Inc. (VIVS) stock is trading at US$0.16, -7.63% from the previous close of US$0.17.
The market cap for VivoSim Labs, Inc. (VIVS) stock is approximately US$3.83M.
The 52-week high for VivoSim Labs, Inc. (VIVS) stock is US$3.40.
The 52-week low for VivoSim Labs, Inc. (VIVS) stock is US$0.16.
VivoSim Labs, Inc. (VIVS) does not currently pay a dividend.
Stay on top of VIVS
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
